StonvexLoading…
StonvexStonvexStonvexCore line items from CNTY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $137.24M | $572.98M | $434.98M | $281.26M |
Operating Income | $11.76M | $51.28M | $40.84M | $23.71M |
Net Income | $-16.50M | $-61.42M | $-43.47M | $-32.92M |
EPS (Diluted) | $-0.58 | $-2.04 | $-1.43 | $-1.08 |
Total Assets | $1.12B | $1.15B | $1.16B | $1.18B |
Total Liabilities | $1.15B | $1.15B | $1.15B | $1.16B |
Cash & Equivalents | $59.96M | $68.92M | $77.69M | $85.54M |
Free Cash Flow OCF − CapEx | $-3.94M | $-15.26M | $-10.57M | $-5.84M |
Shares Outstanding | 28.46M | 28.73M | 29.65M | 30.25M |